Search Results - "Shitaka, Yoshitsugu"
-
1
Repetitive Closed-Skull Traumatic Brain Injury in Mice Causes Persistent Multifocal Axonal Injury and Microglial Reactivity
Published in Journal of neuropathology and experimental neurology (01-07-2011)“…Repetitive mild or "concussive" traumatic brain injury (TBI) can cause substantial neurologic impairment, but the pathological features of this type of injury…”
Get full text
Journal Article -
2
Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine
Published in European journal of pharmacology (05-03-2013)“…Alzheimer's disease is characterized by a progressive decline in cognitive function and involves β-amyloid (Aβ) in its pathogenesis. To characterize cognitive…”
Get full text
Journal Article -
3
Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease
Published in Neuroscience letters (05-02-2015)“…•We have established a novel mouse model of Alzheimer’s disease (the APP/DAL mouse).•Pathological changes and memory impairment are accelerated in the APP/DAL…”
Get full text
Journal Article -
4
Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer’s disease
Published in Brain research (24-04-2015)“…Abstract Stem cell transplantation therapy is currently in clinical trials for the treatment of ischemic stroke, and several beneficial aspects have been…”
Get full text
Journal Article -
5
Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models
Published in Brain research (29-01-2008)“…Abstract We describe in vitro properties and in vivo neuroprotective effects of a newly synthesized, high-affinity, selective allosteric metabotropic glutamate…”
Get full text
Journal Article -
6
Radioligand binding properties and pharmacological characterization of 6-amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1
Published in The Journal of pharmacology and experimental therapeutics (01-10-2005)“…Metabotropic glutamate receptor type 1 (mGluR1) is thought to play important roles in the neurotransmission and pathogenesis of several neurological disorders…”
Get more information
Journal Article -
7
Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models
Published in European journal of pharmacology (24-09-2007)“…Metabotropic glutamate receptor 1 (mGlu 1 receptor) has been suggested to play an important role in pain transmission. In this study, the effects of a…”
Get full text
Journal Article -
8
Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice
Published in The Journal of neuroscience (08-02-2012)“…γ-Secretase inhibitors (GSIs) reduce amyloid-β (Aβ) peptides but inevitably increase the β-C-terminal fragment (β-CTF) of amyloid precursor protein (APP),…”
Get full text
Journal Article -
9
Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble A beta 42 without affecting other A beta pools
Published in Journal of neurochemistry (01-05-2013)“…Given that amyloid- beta 42 (A beta 42) is believed to be a culprit in Alzheimer's disease (AD), reducing A beta 42 production should be a potential…”
Get full text
Journal Article -
10
Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates
Published in Neuropharmacology (01-04-2014)“…γ-Secretase is the enzyme responsible for the intramembranous proteolysis of various substrates, such as amyloid precursor protein (APP) and Notch. Amyloid-β…”
Get full text
Journal Article -
11
Amelioration of cognitive deficits in plaque‐bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools
Published in Journal of neurochemistry (01-05-2013)“…Given that amyloid‐β 42 (Aβ42) is believed to be a culprit in Alzheimer's disease (AD), reducing Aβ42 production should be a potential therapeutic approach…”
Get full text
Journal Article -
12
Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble A[beta]42 without affecting other A[beta] pools
Published in Journal of neurochemistry (01-05-2013)“…Given that amyloid-[beta] 42 (A[beta]42) is believed to be a culprit in Alzheimer's disease (AD), reducing A[beta]42 production should be a potential…”
Get full text
Journal Article -
13
Amelioration of cognitive deficits in plaque‐bearing A lzheimer's disease model mice through selective reduction of nascent soluble A42 without affecting other A pools
Published in Journal of neurochemistry (01-05-2013)“…Abstract Given that amyloid‐β 42 (Aβ42) is believed to be a culprit in Alzheimer's disease ( AD ), reducing Aβ42 production should be a potential therapeutic…”
Get full text
Journal Article -
14
Characterization of cognitive functions of Tg2576 mouse model for Alzheimer's disease with multiple cognitive tasks
Published in Alzheimer's & dementia (01-07-2010)Get full text
Journal Article -
15
P1‐143: Characterization of cognitive functions of Tg2576 mouse model for Alzheimer's disease with multiple cognitive tasks
Published in Alzheimer's & dementia (01-07-2010)Get full text
Journal Article -
16
Progress in the development of anti-amyloid drugs for treatment of Alzheimer's disease.
Published in Nihon yakurigaku zasshi (2010)Get more information
Journal Article -
17
Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease
Published in Acta neuropathologica (01-11-2004)“…Progression of neuritic dystrophy is a histological hallmark of Alzheimer's disease (AD) in addition to amyloid deposition and neurofibrillary tangle…”
Get full text
Journal Article -
18
P3‐298: In vivo efficacy of BACE‐1 inhibitor CTS21166 (ASP1702) in rat CNS compartments
Published in Alzheimer's & dementia (01-07-2009)Get full text
Journal Article -
19
Basic Fibroblast Growth Factor Increases Functional L-Type Ca2+ Channels in Fetal Rat Hippocampal Neurons: Implications for Neurite Morphogenesis In Vitro
Published in The Journal of neuroscience (15-10-1996)“…Basic fibroblast growth factor (bFGF) is a potent neurotrophic factor that regulates cell proliferation and differentiation during neuronal development. Here…”
Get full text
Journal Article -
20